Bethyl Laboratories
Rabbit anti-Mouse Irisin (FNDC5) Antibody Affinity Purified
Primary
Catalog #A306-100A
TargetIrisin
HostRabbit
ClonalityPolyclonal
ReactivityMouse
ApplicationELISA, WB

local_shipping
Order within 3 hours and 38 minutes for shipment by Tuesday, November 24
Product Description
The exercise-inducible myokine Irisin (Boström, et al. 2012) is secreted by cleavage from the transmembrane precursor, FNDC5. Circulating Irisin govern a wide variety of cellular processes relevant to browning, angiogenesis, wound healing, bone mass, and metabolism.
Specifications
Clonality
Polyclonal
Host
Rabbit
Immunogen
Recombinant Irisin constructed from the coding sequence of mouse (NM 027402.3).
Isotype
IgG
Reactivity
Mouse
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Antigen Affinity Purified
Concentration
1 mg/ml
Target Identity
TargetIrisin
Antigen Species
Mouse
Gene ID384061
Gene Symbol
Fndc5
Gene Name
fibronectin type III domain containing 5
Uniprot IDQ8K4Z2
Protein Name
Fibronectin type III domain-containing protein 5
Product Information
Applications
ELISA, WB
Buffer
75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, pH 7.2
Storage Conditions
2 - 8 °C
Physical State
Liquid
Country of Origin
USA
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of cell lysates are performed using Goat anti-Rabbit IgG Heavy and Light Chain Antibody (A120-101P).
Enzyme-Linked Immunosorbent Assay (ELISA)1:1000 - 1:4000
Western Blot (WB)1:1000 - 1:4000
Documents
Safety Data SheetPDF · A306-100AOpen
Product DatasheetPDF · A306-100A · Lot 0 (current lot)Open
Safety Data SheetPDF · A306-100AOpen
Product DatasheetPDF · A306-100A · Lot 0 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



